$ETBI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EASTGATE BIOTECH CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in EASTGATE BIOTECH CORP. Get notifications about new insider transactions in EASTGATE BIOTECH CORP for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | Hasanagic Mirjana Mira | Director | Option Exercise | P | 0.04 | 721,375 | 28,855 | 1,358,575 | |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | Hasanagic Mirjana Mira | Director | Buy | P | 0.04 | 721 | 29 | 7,202,488 | 7.2 M to 7.2 M (+0.01 %) |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | Lukian Brian | CFO | Option Exercise | P | 0.04 | 1,036,475 | 41,459 | 1,896,875 | |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | Lukian Brian | CFO | Buy | P | 0.04 | 1,036,475 | 41,459 | 7,792,394 | 6.8 M to 7.8 M (+15.34 %) |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | SCHWARZ JOSEPH | CSO | Option Exercise | P | 0.04 | 1,121,250 | 44,850 | 1,517,250 | |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | SCHWARZ JOSEPH | CSO | Buy | P | 0.04 | 1,121,250 | 44,850 | 8,724,114 | 7.6 M to 8.7 M (+14.75 %) |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | WEISSPAPIR MICHAEL | CMO | Option Exercise | P | 0.04 | 1,121,250 | 44,850 | 1,517,250 | |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | WEISSPAPIR MICHAEL | CMO | Buy | P | 0.04 | 1,121,250 | 44,850 | 8,724,144 | 7.6 M to 8.7 M (+14.75 %) |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | GLUSKIN ANNA E | Director | Option Exercise | P | 0.04 | 1,243,750 | 49,750 | 2,251,750 | |
| Jan 21 2015 | ETBI | EASTGATE BIOTECH C ... | GLUSKIN ANNA E | Director | Buy | P | 0.04 | 1,243,750 | 49,750 | 12,193,688 | 10.9 M to 12.2 M (+11.36 %) |
| Nov 12 2014 | ETBI | EASTGATE BIOTECH C ... | SCHWARZ JOSEPH | CSO | Buy | P | 0.06 | 636,364 | 35,000 | 3,700,364 | 3.1 M to 3.7 M (+20.77 %) |
| Nov 12 2014 | ETBI | EASTGATE BIOTECH C ... | WEISSPAPIR MICHAEL | CMO | Buy | P | 0.06 | 636 | 35 | 3,700,364 | 3.7 M to 3.7 M (+0.02 %) |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | TGT INVESTMENT MANAGEMENT INC. | 10% Owner | Option Exercise | P | 0.25 | 320,400 | 80,100 | 860,400 | |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | TGT INVESTMENT MANAGEMENT INC. | 10% Owner | Buy | P | 0.25 | 427,200 | 106,800 | 11,147,200 | 10.7 M to 11.1 M (+3.99 %) |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | Hasanagic Mirjana Mira | President | Option Exercise | P | 0.25 | 205,200 | 51,300 | 637,200 | |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | Hasanagic Mirjana Mira | President | Buy | P | 0.25 | 273,600 | 68,400 | 2,849,600 | 2.6 M to 2.8 M (+10.62 %) |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | Lukian Brian | CFO | Option Exercise | P | 0.25 | 320,400 | 80,100 | 860,400 | |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | Lukian Brian | CFO | Buy | P | 0.25 | 427,200 | 106,800 | 1,647,200 | 1.2 M to 1.6 M (+35.02 %) |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | SCHWARZ JOSEPH | CSO | Option Exercise | P | 0.25 | 36,000 | 9,000 | 396,000 | |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | SCHWARZ JOSEPH | CSO | Buy | P | 0.25 | 188,000 | 47,000 | 2,668,000 | 2.5 M to 2.7 M (+7.58 %) |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | WEISSPAPIR MICHAEL | CMO | Option Exercise | P | 0.25 | 36,000 | 9,000 | 396,000 | |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | WEISSPAPIR MICHAEL | CMO | Buy | P | 0.25 | 188,000 | 47,000 | 2,668,000 | 2.5 M to 2.7 M (+7.58 %) |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | GLUSKIN ANNA E | CEO | Option Exercise | P | 0.25 | 360,000 | 90,000 | 1,008,000 | |
| Jul 14 2014 | ETBI | EASTGATE BIOTECH C ... | GLUSKIN ANNA E | CEO | Buy | P | 0.25 | 480,000 | 120,000 | 4,844,000 | 4.4 M to 4.8 M (+11.00 %) |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | WEISSPAPIR MICHAEL | CMO | Option Exercise | P | 0.25 | 360,000 | 90,000 | 360,000 | |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | WEISSPAPIR MICHAEL | CMO | Buy | P | 0.25 | 480,000 | 120,000 | 2,480,000 | 2 M to 2.5 M (+24.00 %) |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | SCHWARZ JOSEPH | CSO | Option Exercise | P | 0.25 | 360,000 | 90,000 | 360,000 | |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | SCHWARZ JOSEPH | CSO | Buy | P | 0.25 | 480,000 | 120,000 | 2,480,000 | 2 M to 2.5 M (+24.00 %) |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | Lukian Brian | CFO | Option Exercise | P | 0.25 | 540,000 | 135,000 | 540,000 | |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | Lukian Brian | CFO | Buy | P | 0.25 | 720,000 | 180,000 | 1,220,000 | 500 K to 1.2 M (+144.00 %) |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | Hasanagic Mirjana Mira | President | Option Exercise | P | 0.25 | 432,000 | 108,000 | 432,000 | |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | Hasanagic Mirjana Mira | President | Buy | P | 0.25 | 576,000 | 144,000 | 2,576,000 | 2 M to 2.6 M (+28.80 %) |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | GLUSKIN ANNA E | CEO | Option Exercise | P | 0.25 | 648,000 | 162,000 | 648,000 | |
| Mar 31 2014 | ETBI | EASTGATE BIOTECH C ... | GLUSKIN ANNA E | CEO | Buy | P | 0.25 | 864,000 | 216,000 | 4,364,000 | 3.5 M to 4.4 M (+24.69 %) |
Page: 1